Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

August 18, 2017August 18, 2017

Sprycel-induced PAH Seen to Persist for Years in Sizable Number of Leukemia Patients in Study

News, PAH News

A treatment given people with chronic myelogenous leukemia (CML) — Sprycel (dasatinib) — is known to cause pulmonary arterial hypertension (PAH) in some. Now, researchers in France report that PAH ... Read more

August 16, 2017August 16, 2017

Reviva’s RP5063 Prevented Rats from Developing Pulmonary Hypertension, Study Reports

News, PAH News

Reviva Pharmaceuticals‘ RP5063 prevented rats from developing pulmonary arterial hypertension (PAH), according to a Canadian study. In addition to precluding heart and blood vessel damage in the animals, RP5063 decreased levels ... Read more

August 11, 2017

Human Cardiotrophin 1 Protein Improves Heart Function in Rats with PAH, Study Shows

News

Human cardiotrophin 1 protein (hCT1) stimulates heart muscle growth in rats with induced right heart failure (RHF) due to severe pulmonary arterial hypertension, leading to improved heart function, a new study shows. The ... Read more

August 7, 2017

Combination of Biomarkers Identified That Predicts Disease Progression in IPH

News

The ratio between the proteins MMP2 and TIMP4 in blood samples of idiopathic pulmonary arterial hypertension (iPAH) patients was found to predict disease worsening and mortality in a German study. ... Read more

July 27, 2017July 27, 2017

Survival Rate Is Higher for PH Patients Who Are Put on a Transplant Priority List, Study Shows

News, PAH News, PH News

The survival rate of pulmonary hypertension patients who received heart and lung transplants increased after France began giving transplant priority to those experiencing life-threatening episodes, a study reports. The ... Read more

June 30, 2017June 30, 2017

Higher Mortality After Bilateral Lung Transplant in Patients with Both COPD and Pulmonary Hypertension, Study Finds

News, PH News

Pulmonary hypertension (PH) in patients with chronic obstructive pulmonary disease (COPD) was associated with higher mortality rates after bilateral lung transplantation (transplantation of both lungs), but not after single ... Read more

June 23, 2017June 23, 2017

Treprostinil-linked Adverse Events not Associated with Mortality in All PAH Patients

News, PAH News

Adverse drug events (ADEs) associated with subcutaneous treprostinil use for the treatment of pulmonary arterial hypertension (PAH) were found not to be associated with a higher mortality risk, except for ... Read more

June 19, 2017June 19, 2017

Chronic Thromboembolic Pulmonary Hypertension Patients Still Benefit Six Months After Balloon Angioplasty

News

Balloon pulmonary angioplasty, a procedure to widen narrowed lung blood vessels, was still benefitting patients with chronic thromboembolic pulmonary hypertension (CTEPH) six months after doctors performed it, a Japanese study ... Read more

May 19, 2017May 19, 2017

Exercise-capacity Builder Tracleer May Decrease Impact of Two Other PAH Therapies, Revatio and Adcirca

News, PAH News

Tracleer, which improves pulmonary arterial hypertension patients’ exercise capability, may decrease the effectives of two other PAH treatments, Revatio and Adcirca, according to a study. One of the problems with ... Read more

April 17, 2017April 17, 2017

Study Identifies New Gene Mutations Associated with Heritable PAH

News, PAH News

A Japanese study of nine families members who have heritable pulmonary arterial hypertension (HPAH) found different mutations in the same gene, called BMPR2, four of which had been identified before and ... Read more